Table 4.

Correlations with Clinical Outcomes for Studies 1–3

	Reappraisal	Suppression
Study 1 (PLE: n = 262)
SDQ Emotional Symptoms	.26***	.43***
SDQ Conduct Problems	.08	.22***
SDQ Hyperactivity	−.03	.20**
SDQ Peer Problems	−.10	.16*
SDQ Prosocial	.51***	.34***
YPARQ-B Total	−.19**	−.21**
Study 2 (CHR: n = 29)
SIPS Positive	.11	−.02
SIPS Negative	−.11	.32
SIPS Disorganized	.17	−.22
SIPS General	−.40*	−.30
BNSS Anhedonia	−.16	.16
BNSS Avolition	.03	.17
BNSS Asociality	−.45*	.05
BNSS Blunted Affect	−.15	.37
BNSS Alogia	−.12	.32
Study 3 (SZ: rc = 61)
BPRS Positive	−.14	.22
BPRS Negative	−.09	−.05
BPRS Disorganized	.19	.07
BPRS Total	−.14	.13
BNSS Anhedonia	−.33**	−.10
BNSS A volition	−.08	−.13
BNSS Asociality	−.33**	.07
BNSS Blunted Affect	−.17	.04
BNSS Alogia	−.19	−.08
LOF Social	.17	−.09
LOF Work	.06	.11

Note.

^***p < 0.001;

^**p < 0.01;

^*p < 0.05.

PLE = individuals with psychotic-like experiences; CHR = individuals at clinical high-risk; SZ = schizophrenia outpatients; SDQ = Strengths and Difficulties Questionnaire; SIPS = Structured Interview for Psychosis-Risk Syndromes; BNSS = Brief Negative Symptom Scale; BPRS = Brief Psychiatric Rating Scale; LOF = Level of Function Scale.